HANEEN ISSA: Open Payments
NPI 1366162208 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,975 in 81 payments from 19 companies in 2025. Trend: 2023 $2,618 · 2024 $2,460 · 2025 $1,975
Food & beverage: $1,875Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $307 |
| REVANCE THERAPEUTICS, INC. | 3 | $277 |
| Janssen Biotech, Inc. | 13 | $222 |
| UCB, Inc. | 8 | $213 |
| MERZ NORTH AMERICA, INC. | 1 | $157 |
| Regeneron Healthcare Solutions, Inc. | 4 | $106 |
| Novartis Pharmaceuticals Corporation | 4 | $99 |
| Incyte Corporation | 4 | $89 |
| Arcutis Biotherapeutics, Inc. | 5 | $87 |
| Galderma Laboratories, L.P. | 4 | $78 |
Products named: DAXXIFY, TREMFYA, Bimzelx, DUPIXENT, NATRELLE SALINE-FILLED BREAST IMPLANTS, OPZELURA, Zoryve, SKYRIZI.
Industry payments across TX — which companies pay providers there.
